TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Wednesday reported a loss of $5.6 million in its fourth quarter.
On a per-share basis, the Toronto-based company said it had a loss of $1.16.
The drug developer posted revenue of $121,000 in the period.
For the year, the company reported that its loss narrowed to $16.6 million, or $3.41 per share. Revenue was reported as $4.5 million.
The company’s shares closed at $2. A year ago, they were trading at $2.63.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
